Survival in Patients With Hematologic Cancers and COVID-19
This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.
This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.
This Special Communication analyzes and compares development times, clinical trial success rates, research and development costs, patent protection, market exclusivity periods, revenues, and treatment costs…
Scientists are uneasy about NIH research funding priorities and Trump’s pick to lead the NIH, Jay Bhattacharya
The FDA has approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult solid tumor nivolumab (Opdivo) indications.
A video from Jean-Jacques Kiladjian (as part of 2024 ASH Annual Meeting Insights Hub), posted on Dec 18, 2024.
We are now accepting applications for the summer 2025 program! Apply for CanSUR Cancer-focused Summer Undergraduate Research (CanSUR) is a National …
This cross-sectional study evaluates whether an investigational handheld ultra-widefield optical coherence tomography device without scleral depression can be used to document high-quality images of the…
This multicenter cohort study develops and assesses the validity of a deep learning model for predicting immune checkpoint inhibitor response in patients with advanced non−small…
This JAMA Pediatrics Patient Page discusses children’s ability to learn and use multiple languages.
This quasi-experimental survey study evaluates the association of restrictions on flavored electronic nicotine delivery systems with vaping and cigarette smoking among 18- to 29-year-old individuals…
This Medical News article is an interview with Stanford University’s Jonathan Chen, MD, PhD, and Ethan Goh, MBBS, MS, about their research on AI tools…